Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.
Sophie L V M StroeksDebby M E I HellebrekersGodelieve R F ClaesUpasana TayalIngrid P C KrapelsEls K VanhoutteArthur van den WijngaardMichiel T H M HenkensJames S WareStephane R B HeymansHan G BrunnerJob A J VerdonschotPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2021)
Stringent gene selection for DCM genetic testing reduced the number of VUS while retaining ability to detect similar P/LP variants. The number of genes on diagnostic panels should be limited to genes that have the highest signal to noise ratio.